ZLE:CA:TSX-BMO Low Volatility Emerging Markets Equity ETF (CAD)

ETF | Emerging Markets Equity |

Last Closing

CAD 19.95

Change

0.00 (0.00)%

Market Cap

N/A

Volume

300.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Emerging Markets Equity

Symbol Name Price(Change) Market Cap
XSEM:CA iShares ESG MSCI Emerging Mark..

+0.13 (+0.60%)

CAD 3.14B
XEC:CA iShares Core MSCI Emerging Mar..

+0.14 (+0.47%)

CAD 1.80B
ZEM:CA BMO MSCI Emerging Markets Inde..

+0.13 (+0.58%)

CAD 1.07B
XEM:CA iShares MSCI Emerging Markets ..

+0.18 (+0.53%)

CAD 0.20B
DRFE:CA Desjardins RI Emerging Markets..

-0.45 (-1.87%)

CAD 0.08B
XMM:CA iShares MSCI Min Vol Emerging ..

-0.06 (-0.20%)

CAD 0.06B
RXD:CA RBC Quant Emerging Markets Div..

-0.01 (-0.05%)

CAD 0.04B
VEE:CA Vanguard FTSE Emerging Markets

+0.20 (+0.51%)

N/A

ETFs Containing ZLE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Emerging Markets Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.56% 67% D+ 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.56% 56% F 67% D+
Trailing 12 Months  
Capital Gain 17.46% 22% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.46% 33% F 42% F
Trailing 5 Years  
Capital Gain -4.55% 11% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.55% 11% F 21% F
Average Annual (5 Year Horizon)  
Capital Gain -3.07% N/A N/A 18% F
Dividend Return -2.55% N/A N/A 15% F
Total Return 0.52% N/A N/A 29% F
Risk Return Profile  
Volatility (Standard Deviation) 9.17% N/A N/A 84% B
Risk Adjusted Return -27.78% N/A N/A 13% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike